Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Growth Factor Inhibition

Growth Factor Inhibition involves interference with, or restraint of, the activities of extracellular signaling molecules (ligands) involved in the… Expand
National Institutes of Health

Related topics

Related topics

7 relations
AE-941Protein Sprouty Homolog 4SPRY4 geneSuramin
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition
OBJECTIVES This study postulated that antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibition may… Expand
  • figure 1
2016
2016
Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
Background Antiangiogenic therapy of vestibular schwannoma (VS) in type 2 neurofibromatosis can produce tumor shrinkage with… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2014
Highly Cited
2014
Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model.
To inhibit vascular changes in diabetic retinopathy, inhibiting vascular endothelial growth factor (VEGF) has become a mainstay… Expand
Highly Cited
2012
Highly Cited
2012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
PURPOSE To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic macular edema (DME) patients. DESIGN Two… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 3
2012
2012
Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up.
PURPOSE To compare the long-term results of the efficacy of photodynamic therapy (PDT) with or without intravitreal bevacizumab… Expand
Highly Cited
2007
Highly Cited
2007
Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition.
Vascular endothelial growth factor (VEGF) receptor blockade impairs lung growth and decreases nitric oxide (NO) production in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
Combined Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Inhibition in Rat Cardiac Allografts: Beneficial Effects on Inflammation and Smooth Muscle Cell Proliferation
Background. Perivascular inflammation and subsequent smooth muscle cell (SMC) proliferation are central in the development of… Expand
Highly Cited
1995
Highly Cited
1995
Effects of low and high doses of fosinopril on the structure and function of resistance arteries.
It has been suggested that angiotensin-converting enzyme inhibitors may induce a significant regression of cardiovascular… Expand
Highly Cited
1987
Highly Cited
1987
Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
The combination of a long-acting delivery system for the agonist [D-Trp6]luteinizing hormone-releasing hormone ([D-Trp6]LH-RH… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
1986
1986
Insulin-like growth factor inhibition of growth hormone secretion.
  • M. Sheppard, R. Bala
  • Canadian journal of physiology and pharmacology
  • 1986
    • Corpus ID: 27337179
Somatomedins-insulin-like growth factors (SM/IGF) are growth hormone (GH) dependent serum growth factors. There is some evidence… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE